APPLICATION
ANDA084579
TYPE
ANDA
ORIGINAL APPROVAL
1975-09-30
LATEST ACTION
1992-02-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
RESERPINE AND HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 50MG, RESERPINE 0.125MG · TABLET · ORAL
Approval history
1992-02-14Labeling · Supplement 37AP
1991-01-22Labeling · Supplement 36AP
1989-08-23Labeling · Supplement 35AP
1989-06-16Labeling · Supplement 33AP
1989-03-24Labeling · Supplement 34AP
1975-09-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.